Clinical Role - Retail
Skidki-na-vse® is the most trusted resource as it pertains to providing the latest industry news and information to retail pharmacists and reaches more than 200,000 total pharmacy professionals.
Trifarotene is the only topical retinoid that selectively targets retinoic acid receptor (RAR) gamma, the most common RAR found in the skin. The cream is also the first topical treatment specifically studied and proven to treat both facial (forehead, cheeks, nose, and chin) and truncal (chest, shoulders, and back).
Walter Wong, PharmD, owner of Green Valley Pharmacy in Rancho Cucamongo, CA speaks to Pharmacy Times about how his pharmacy's services help providers in the latest addition to Skidki-na-vse' Independent Corner.
Suzy Soliman, PharmD, discusses why October 12 was chosen to recognize Women Pharmacist Day.
A new study by Prime Therapeutics LLC has shown a sharp increase in the number of drug "super spenders," defined by the researchers as members with pharmacy and medical drug therapy claims of $250,000 or more annually.
The key opinion leader discusses the patient education needed and how pharmacists can improve their knowledge.
The FDA has awarded a cooperative agreement grant to the National Association of Boards of Pharmacy to develop a 3-year pilot project for a data-sharing system to improve oversight of compounding pharmacies.
The FDA is continuing to test ranitidine products from multiple manufacturers following the discovery of impurities in low levels in some medicines, including Zantac.
Oprah Winfrey’s message is clear: the flu and pneumonia vaccines are important.
Two lawsuits against the FDA have been resolved in a conclusion favorable to Endo International, which argued that vasporessin should be excluded from the agency’s compounding list.
Johnson & Johnson and its Janssen Pharmaceutical Cos unit have agreed to a more than $10 million settlement, rather than allowing the matter go to federal trial.
The National Institute of Allergy and Infectious Diseases (NIAID), which is a part of the National Institute of Health, has developed the Collaborative Influenza Vaccine Innovation Centers (CIVICs) program.
Christopher Altman, PharmD, provides an understanding of the in-home drug testing.
+ Load More